Clinical Trials in Arizona

Showing 7421-7440 of 12,706 trials

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

NCT01649336

This is a Phase 1 study during which patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer will receive investigational study drug MEK162 and paclitaxel. Patients will receive increasing doses of study drug in combination with paclitaxel in order to achieve the highest dose of study drug possible that will not cause unacceptable side effects. Patients will be followed to see what side effects the combination causes and what effectiveness the combination has, if any, in treating the cancer. Approximately 36 patients from the US will be enrolled in this study.

Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer

Array Biopharma, now a wholly owned subsidiary of Pfizer36 participantsStarted Jul 2012

Scottsdale, Arizona, United States • Lafayette, Indiana, United States • New York, New York, United States +1 more locations

TERMINATEDPhase 235 miles

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

NCT03382912

To compare the efficacy of pegilodecakin in combination with nivolumab versus nivolumab alone in participants with metastatic non-small cell lung cancer as measured by objective response rate.

Non Small Cell Lung Cancer

Eli Lilly and Company52 participantsStarted Mar 2018

Tempe, Arizona, United States • Beverly Hills, California, United States • Los Angeles, California, United States +32 more locations

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Find Trials by Condition in Arizona

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

A Study of TRV130 for the Treatment of Pain After Bunionectomy

PROMINENT-Eye Ancillary Study (Protocol AD)

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical Evaluation of Flortaucipir F 18

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Behavioral Therapy Of Obstetric Sphincter Tears

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Dose Finding Study to Treat High Phosphate Levels in the Blood.

Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Oral Iron for Erythropoietic Protoporphyrias

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001